NASDAQ:KPTI | Insider Transactions — Page 9 | Karyopharm Therapeutics Inc.

KPTI Insider Transactions — Page 9

826 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 801–826; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Jankilevitsch GregoryOther2014-07-23Sale50,000.0$35.54
Plio LtdTenPercentOwnerOther2014-07-23Sale500,000.0$35.54
Hadjimichael AndreasTenPercentOwner2014-07-23Sale500,000.0$35.54
Hadjimichael AmaliaTenPercentOwner2014-07-23Sale500,000.0$35.54
Czernik MarcinTenPercentOwner2014-07-23Sale500,000.0$35.54
Jankilevitsch GregoryOther2014-07-23Sale500,000.0$35.54
Shacham SharonPresident & CSO2014-07-02Sale100,000.0$42.5
Shacham SharonPresident & CSO2014-07-02Sale100,000.0$42.5
Kauffman MichaelChief Executive Officer2014-07-02Sale100,000.0$42.5
Kauffman MichaelChief Executive Officer2014-07-02Sale100,000.0$42.5
Shacham SharonPresident & CSO2014-06-18Sale10,000.0$43.15
Kauffman MichaelChief Executive Officer2014-06-18Sale10,000.0$43.15
Shacham SharonPresident & CSO2014-06-17Sale10,000.0$40.36
Kauffman MichaelChief Executive Officer2014-06-17Sale10,000.0$40.36
PAKIANATHAN DEEPIKADirector2014-05-23Purchase17.0$26.45
PAKIANATHAN DEEPIKADirector2014-05-23Purchase1,752.0$26.45
PAKIANATHAN DEEPIKADirector2014-05-22Purchase193.0$26.09
PAKIANATHAN DEEPIKADirector2014-05-22Purchase19,807.0$26.09
PAKIANATHAN DEEPIKADirector2014-05-21Purchase896.0$26.19
PAKIANATHAN DEEPIKADirector2014-05-21Purchase91,754.0$26.19
Brannelly PaulSVP, FINANCE & ADMIN, TREAS2014-05-15Purchase700.0$25.95
Brannelly PaulSVP, FINANCE & ADMIN, TREAS2014-05-14Purchase800.0$26.93
Primiano Christopher BrettVP, GEN COUNSEL & SECRETARY2014-05-13Purchase1,000.0$26.75
Brannelly PaulSVP, FINANCE & ADMIN, TREAS2014-05-13Purchase1,000.0$28.06
PAKIANATHAN DEEPIKADirector2013-11-12Purchase3,022.0$16.0
PAKIANATHAN DEEPIKADirector2013-11-12Purchase309,478.0$16.0